Anti-Ro52 antibodies are commonly associated with increased sensitivity to UV light and congenital heart blocks in neonatal lupus erythematosus (NLE), particularly when targeting the p200 epitope. This evidence concerns the gene TRIM21 and neonatal lupus erythematosus.